K. Miller

Pyrazolo-[1,5-a]-1,3,5-triazine corticotropin-releasing factor (CRF) receptor ligands.

K. K. Nanda, W. Marshall, L. Fitzgerald, 2003, Bioorganic & medicinal chemistry.

Arylamidrazones as novel corticotropin releasing factor receptor antagonists.

P. Grootenhuis, A. Termin, M. Ramirez-Weinhouse, 2002, Journal of medicinal chemistry.

Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists.

S. Arneric, G. Trainor, H. Wong, 2009, Journal of medicinal chemistry.

Synthesis and In Vitro Anti-Helicobacter and Anti-Staphylococcal Activities of Novel Diaryldisulfides and Diarylthiosulfonates

Yong Zhou, M. A. Khan, K. Rawson, 2021, Advances in Biological Chemistry.

8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists.

Lawrence Fitzgerald, Ge Zhang, Harvey Wong, 2009, Journal of medicinal chemistry.

2-(3-Methyl-3H-diaziren-3-yl)ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate: a derivative of the stereoselective general anesthetic etomidate for photolabeling ligand-gated ion channels.

R. Olsen, Jonathan B. Cohen, S. Husain, 2003, Journal of Medicinal Chemistry.

Synthesis and evaluation of imidazo[1,5-a]pyrazines as corticotropin releasing hormone receptor ligands.

K. K. Nanda, A. Tebben, L. Fitzgerald, 2002, Bioorganic & medicinal chemistry letters.